
|Articles|May 17, 2004
Study finds patients will pay for osteoporosis screening
Pharmacy-based bone mineral density screening found that 78% of patients were unware of their risk of fractures and 70% of the moderate or high risk patients referred to a physician actually visited the doctor and 24% of those patients were started on therapy, according to the Project ImPACT: Osteoporosis study.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
2
FDA Approves XFG-Targeted COVID-19 Vaccines From Multiple Companies
3
FDA Approves Stelara for Pediatric Ulcerative Colitis
4
COVID-19 in 2026: Why the Virus Still Threatens Vulnerable Patients
5




























